Why is Metropolis Healt falling/rising?

As of 13-Oct, Metropolis Healthcare Ltd's stock price is currently at 1,976.00, reflecting a decrease of 23.95 points or 1.2%. The stock has underperformed today, with a performance that is 2.32% lower than its sector. It reached an intraday low of Rs 1,950.05, which is a decline of 2.5%. Over the past week, the stock has seen a return of -4.53%, while it has also underperformed on a monthly basis with a -4.12% return. Despite having a high management efficiency indicated by a return on capital employed (ROCE) of 26.87% and a low debt-to-equity ratio of 0.10, the stock's recent movement has been negatively impacted by a significant drop in investor participation, with delivery volume falling by 61.54% against the 5-day average.
In the broader market context, while Metropolis Healthcare has struggled with a year-to-date return of -4.23%, the benchmark Sensex has shown a positive return of 5.36% during the same period. This stark contrast highlights the stock's underperformance relative to the market. Additionally, the stock's performance over the last year has been disappointing, with a decline of 12.68%, while the Sensex has only increased by 1.16%. The high institutional holdings at 45.23% suggest that knowledgeable investors are backing the company, but the current market sentiment appears to be weighing heavily on the stock's price.